Success Stories: Start-Ups
Endophys Holdings, LLC is a Dallas-based, privately held medical device company that develops pressure sensing access systems which improve the safety and outcome in critical procedures in cath/angiography labs by providing immediate, continuous, and accurate endovascular physiology. The Company is currently developing a version of the pressure sensing access sheath for use in stroke procedures and expects to have it commercially available in 2017.
Founded in 2014
Exonics Therapeutics, located in Dallas, Texas, is a biotechnology company focused on developing gene editing technologies like CRISPR/Cas9 to correct genetic mutations resulting in neuromuscular diseases such as Duchenne muscular dystrophy. While the company's initial focus is on Duchenne, it looks forward to advancing its gene editing platform to additional pediatric indications with significant unmet medical need.
Founded in 2017
miRagen Therapeutics, Inc. is a clinical stage biopharmaceutical company discovering and developing innovative RNA-targeting therapies to improve human health, with a specific focus on microRNAs and disease areas of high unmet medical needs.
Founded in 2007
Peloton Therapeutics, Inc. is an oncology drug discovery and development company focused on advancing first-in-class small molecule therapies that provide patients suffering from life-threatening diseases with new therapeutic options.
Founded in 2011
Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company committed to improving the lives of patients by delivering high quality pharmaceutical products. The company is working to evaluate its lead immunotherapy candidate, bavituximab, in combination with immune stimulating therapies for the treatment of various cancers, and developing its proprietary exosome technology for the detection and monitoring of cancer.
Founded in 1981
Reata Pharmaceuticals is a biopharmaceutical company based in Irving Texas. Its mission is to develop novel therapeutics for patients with rare and life-threatening diseases by targeting molecular pathways that regulate cellular metabolism and inflammation.
Founded in 2002
Sienna Cancer Diagnostics is a biotechnology company based in Melbourne, Australia. Their focus is the development and commercialization of novel IVD tests that solve unmet clinical needs in the diagnosis or characterization of cancer. Sienna’s primary platform is the detection of the biomarker, telomerase, which is found in nearly all epithelial cancers, and was the subject of a Nobel Prize in 2009.
Founded in 2007
Starr Frame LLC is a privately held company that develops and markets innovative medical products that facilitate orthopaedic and other surgical procedures.
Founded in 2008